Respiratory Medicine
Volume 104, Issue 9 , Pages 1319-1325, September 2010

Sniff nasal inspiratory pressure versus IC/TLC ratio as predictors of mortality in COPD

  • Alastair J. Moore

      Affiliations

    • Respiratory Muscle Laboratory, Royal Brompton Hospital and National Heart Lung Institute, Fulham Road, London SW3 6NP, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 07976 924582; fax: +44 207 351 8939.
  • ,
  • Rosa Suades Soler

      Affiliations

    • Respiratory Muscle Laboratory, Royal Brompton Hospital and National Heart Lung Institute, Fulham Road, London SW3 6NP, UK
    • Experimental Sciences and Health Department, Universitat Pompeu Fabra, Barcelona 88 08003, Spain
  • ,
  • Edward J. Cetti

      Affiliations

    • Respiratory Muscle Laboratory, Royal Brompton Hospital and National Heart Lung Institute, Fulham Road, London SW3 6NP, UK
  • ,
  • S. Amanda Sathyapala

      Affiliations

    • Respiratory Muscle Laboratory, Royal Brompton Hospital and National Heart Lung Institute, Fulham Road, London SW3 6NP, UK
  • ,
  • Nicholas S. Hopkinson

      Affiliations

    • Respiratory Muscle Laboratory, Royal Brompton Hospital and National Heart Lung Institute, Fulham Road, London SW3 6NP, UK
  • ,
  • Michael Roughton

      Affiliations

    • Respiratory Muscle Laboratory, Royal Brompton Hospital and National Heart Lung Institute, Fulham Road, London SW3 6NP, UK
  • ,
  • John Moxham

      Affiliations

    • Respiratory Muscle Laboratory, King's College London School of Medicine, London SE5 9RS, UK
  • ,
  • Michael I. Polkey

      Affiliations

    • Respiratory Muscle Laboratory, Royal Brompton Hospital and National Heart Lung Institute, Fulham Road, London SW3 6NP, UK

Received 16 October 2009; accepted 1 March 2010. published online 20 April 2010.

Summary 

Background

Hyperinflation is a recognized adverse prognostic factor in COPD. As the sniff inspiratory nasal pressure (SnIP) principally reflects the severity of hyperinflation in COPD, we hypothesized that it might also be a predictor of mortality. We therefore compared the SnIP to the inspiratory capacity-to-total lung capacity (IC/TLC) ratio as predictors of mortality in advanced COPD.

Methods

A retrospective mortality analysis of 110 patients with COPD (mean FEV1 1.01litres, 37% predicted; 66% male) was performed. All patients had SnIP and lung volume measurements performed. The power of each test to predict mortality was determined, and predicted survival curves were created for both the SnIP and IC/TLC ratio.

Results

37 patients (34%) died during the study period (29 male, 8 female). Mortality rates were analysed with a Chi2 test; there was a significant trend towards male death (mortality rate male vs. female; 39.7% vs. 21.6% respectively; χ2 p=0.058, Chi 3.6). ROC curves demonstrated that both SnIP and IC/TLC ratio are predictors of mortality, but analysis by Cox proportional hazards suggested the SnIP has a stronger predictive power (SnIP vs. IC/TLC ratio; p=0.017 vs 0.525; HR 0.97 vs 0.99 respectively), and analysis of the area under ROC curves (AUC) suggest that SnIP is a better discriminator than IC/TLC ratio (AUC SnIP vs IC/TLC; 0.679 vs 0.618).

Conclusions

The SnIP conveys at least as much predictive power for mortality in COPD as hyperinflation determined by IC/TLC ratio. This test is cheaper, quicker and easier than measuring lung volumes by plethysmography.

Keywords: COPD, Respiratory muscle strength, Hyperinflation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0954-6111(10)00099-5

doi:10.1016/j.rmed.2010.03.001

Respiratory Medicine
Volume 104, Issue 9 , Pages 1319-1325, September 2010